Curofy
Flibanserin Approval Not Supported by Data, Review Suggests
A review of clinical trial data looking at the safety and efficacy of a drug intended to boost female libido shows the US Food and Drug Administration approved "a marginally effective drug for a non-life-threatening condition in the face of substantial — and unnecessary — uncertainty about its dangers," according to Steven Woloshin, MD, and Lisa M. Schwartz, MD. Click through to read more.
See this content immediately after install